BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17168396)

  • 1. [Antibiotic therapy for patients with respiratory tract infection].
    Kasahara K; Mikasa K
    Nihon Naika Gakkai Zasshi; 2006 Nov; 95(11):2220-4. PubMed ID: 17168396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology and therapy in patients with respiratory tract infections].
    Saito A
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):433-6. PubMed ID: 8315342
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options.
    Zumla A; Memish ZA; Maeurer M; Bates M; Mwaba P; Al-Tawfiq JA; Denning DW; Hayden FG; Hui DS
    Lancet Infect Dis; 2014 Nov; 14(11):1136-1149. PubMed ID: 25189352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-polyenic antifungal macrolide antibiotics].
    Shenin IuD
    Antibiot Khimioter; 1991 Oct; 36(10):50-4. PubMed ID: 1805700
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical position of sitafloxacin in outpatient chemotherapy. (discussion)].
    Niki Y; Aoki N; Suzuki K; Matsumoto T
    Jpn J Antibiot; 2009 Jun; 62(3):179-93. PubMed ID: 19882979
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
    Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
    Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
    [No Abstract]   [Full Text] [Related]  

  • 7. [New antimicrobial drugs: an update].
    Burgmann H
    Wien Med Wochenschr; 2003; 153(7-8):166-8. PubMed ID: 12764871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 2-1. Anaerobic infections (individual fields): respiratory infections.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():42-6. PubMed ID: 21728090
    [No Abstract]   [Full Text] [Related]  

  • 9. Interscience Conference on Antimicrobial Agents and Chemotherapy--44th annual meeting. Drug highlights I. 30 October-2 November 2004, Washington DC, USA.
    Veryard C; Shah S
    IDrugs; 2004 Dec; 7(12):1058-61. PubMed ID: 15599792
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bacterial flora in nontuberculous infections of the respiratory tract (findings relevant to the year 1988)].
    Saviano G; Borrelli G; Cerbone V; Ferrera P; La Gala F; Cuccurullo S; Corsi G
    Arch Monaldi Mal Torace; 1988; 43(6):475-85. PubMed ID: 3155011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Levofloxacin: role and place in the treatment of infections of the lower respiratory tracts].
    Sinopal'nikov AI; Romanovskiĭ AG
    Ter Arkh; 2004; 76(11):51-6. PubMed ID: 15658538
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibiotic therapy of bacterial respiratory tract infections].
    Schauer J
    Z Gesamte Inn Med; 1992 Sep; 47(9):398-403. PubMed ID: 1441667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic resistance: infections of the upper respiratory tract and bronchi. When are antibiotics necessary?].
    Zellweger C; Täuber MG
    Ther Umsch; 2002 Jan; 59(1):21-9. PubMed ID: 11851042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemo-antibiotico-therapy today. I].
    Cairella M; Marasa G
    Clin Ter; 1974 Jun; 69(6):561-84. PubMed ID: 4845638
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic infections.
    Golkar FC; Rosemurgy AS
    Arch Surg; 2011 May; 146(5):619. PubMed ID: 21739658
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistant pathogens in respiratory tract infections in older people.
    Bonomo RA
    J Am Geriatr Soc; 2002 Jul; 50(7 Suppl):S236-41. PubMed ID: 12121519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial resistance].
    Salzberger B; Welte T
    Internist (Berl); 2015 Nov; 56(11):1231-2. PubMed ID: 26507817
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in antimicrobial resistance and outcomes of health care-associated infections.
    Aydın M; Azak E; Bilgin H; Menekse S; Asan A; Mert HTE; Yulugkural Z; Altunal LN; Hatipoğlu ÇA; Tuncer Ertem G; Altunok ES; Demirkaya MH; Çeviker SA; Akgul F; Memis Z; Konya P; Azap A; Aydin G; Korkmaz D; Karakoç ZÇ; Yapar D; Karakecili F; Gunal O; Keske S; Kapmaz M; Kader C; Demirel A; Ergönül Ö
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1737-1742. PubMed ID: 33586014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microbiological causes of antibiotic therapy failure in respiratory tract infections].
    Kozioł-Montewka M
    Pol Merkur Lekarski; 2011 May; 30(179):373-6. PubMed ID: 21675146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on antibacterial and antifungal drugs - can we master the resistance crisis?
    Theuretzbacher U; Mouton JW
    Curr Opin Pharmacol; 2011 Oct; 11(5):429-32. PubMed ID: 21903474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.